The completion of a large-scale biomarker validation study led by Proteome Sciences is a “major step” towards developing a series of simple blood tests that would facilitate early diagnosis and management of Alzheimer’s disease (AD), both in clinical trials and clinical practice, the company says.
Read MoreThe Cameron government has pledged to more than double annual funding for research into dementia and neurodegenerative diseases to over £66 million by 2014/15.
Read MoreCetero Research, the early-phase contract research organisation (CRO) hit last year by FDA claims of “significant instances of misconduct and violations” at the company’s facility in Houston, Texas, has filed for Chapter 11 bankruptcy protection amid mounting financial problems.
Read MoreThe International Academy of Clinical Research (IAoCR) has launched a campaign to change the way training and education are conducted in the UK’s clinical research industry.
Read MoreUS-based biopharmaceutical services company Quintiles is collaborating with the Malaysian Biotechnology Corporation (BiotechCorp), the lead development agency for the biotech industry in Malaysia, as part of BiotechCorp’s efforts to foster a supportive national environment for clinical research.
Read More
